Source: International Congress 2015 – New data on established treatments for asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Özlem Göksel (Izmir, Turkey), Ozlem Goksel, Rukiye Vardar, Haydar S. Karakus, Yasemin Alev, Esra Yildirim, Munevver Erdinc, Serhat Bor. The effects of inhaler B-2 adrenergic agonists on esophaeal high resolution manometry pressure metrics in asthma patients with inadequate symptom control (Ege University reflux group). Eur Respir J 2015; 46: Suppl. 59, 1011

Member's Comments

No comment yet.

Related content which might interest you: Improved effects of aerosol-type fluticasone propionate/formoterol combination on residual asthmatic inflammation in distal airways of patients with moderate asthma Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Association between cardio-ankle vascular index (CAVI) and chronic airway obstruction in asthma Source: International Congress 2016 – Monitoring comorbidities Year: 2016 Effects of extra fine formoterol or coarse particle salmeterol on impulse oscillometry (IOS) in corticosteroid treated persistent asthmatics Source: International Congress 2015 – Safety of and interactions between current treatments for asthma and COPD Year: 2015 The effect of inhaled ciclesonide on airway blood flow Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013 Comparison of inspiratory flow rates using an innovative dry powder inhaler (DPI) in patients with mild–severe asthma and severe COPD Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Effect of different inhalation methods on the airway clearance in moderate and severe AECOPD Source: International Congress 2016 – Pharmacological management of COPD Year: 2016 Long-acting anticholinergics in the treatment of severe asthma with irreversible airway obstruction Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014 Pharmacologic bronchodilation response to salbutamol in COPD patients Source: International Congress 2014 – Predictors Year: 2014 Short-term effects of bronchial thermoplasty on pulmonary function in patients with severe asthma Source: International Congress 2016 – Airway stenting and ablation Year: 2016 BioPhysical bronchodilator: A new class of respiratory drug Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015 Are ultrafine particle inhalers, better for patients with small airway involvement? Source: International Congress 2014 – Novel evidence relating to respiratory treatment development Year: 2014 Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Investigating the interaction between bronchoconstriction and cough in asthma Source: International Congress 2016 – Clinical studies in asthma and immunology Year: 2016 Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 Effect of inhaled vilanterol trifenatate/fluticasone furoate on breathing pattern, dyspnea and respiratory muscle function in severe COPD Source: International Congress 2014 – Clinical trials of drugs for respiratory diseases Year: 2014 Effect of short-acting bronchodilators (BDs) on the severity of respiratory muscle (RM) strength in COPD patients (pts) Source: Annual Congress 2013 –COPD treatment Year: 2013 Effect of cromolyn inhaler on resistant neutrophilic cough variant of asthma, A phase two clinical trial Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Preference, satisfaction and critical errors with Genuair® and Breezhaler® in patients with COPD Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014 Exaggerated airway narrowing is related to increased airway smooth muscle mass in bronchial segments from subjects with a history of asthma Source: Annual Congress 2013 –Airway smooth muscle and cell biology Year: 2013 The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children Source: Annual Congress 2013 –Asthma treatment and management in children Year: 2013